Connect Biopharma Holdings Limited Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Connect Biopharma Holdings Limited (CNTB) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of $162.00 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2024-09-05
CNY
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 6 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|---|
| 2023-06-30 | 3.43M CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | 9.63M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | 7.76M CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | -3.31M CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | -741.00K CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | -6.77M CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | 2.25M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 6 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|---|
| 2024-06-30 | $162.00K 6-K · filed 2024-09-05 | |
| 2023-12-31 | $367.00K 20-F · filed 2024-04-16 | |
| 2023-06-30 | $481.00K 6-K · filed 2024-09-05 | |
| 2022-12-31 | $1.47M 20-F · filed 2024-04-16 | |
| 2021-12-31 | -$516.00K 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |